Related by context. All words. (Click for frequent words.) 63 Randomized Phase 63 phase IIIb 62 Initiated Phase 61 PRECISE 60 BOLDER 60 ARBITER 6 60 Pivotal Phase 59 ASTEROID 59 placebo controlled Phase 59 label multicenter Phase 59 ATTRACT 59 Aggressive Reduction 59 Multicenter 59 ONTARGET 59 Prospective Randomized 59 RIBBON 59 LUX Lung 59 STENT 58 PERISCOPE 58 Acute Ischemic Stroke 58 RADIANT 58 brivaracetam 58 GOUT 58 HALTS 58 BLOSSOM 58 CABERNET 58 RE LY 57 Ranolazine 57 Drug Eluting Stent System 57 Initiate Phase 57 ACCLAIM 57 multicentre randomized 57 QNEXA 57 AVANDIA 57 ADVANCE PD 57 Degludec 57 Phase IIB 57 DURATION 57 Phase IIIb 56 CLINICAL TRIAL 56 PFO migraine 56 STRIDE PD 56 RhuDex 56 Acute Myocardial Infarction 56 Dose Ranging Study 56 PREVAIL 56 Confirmatory Phase 56 prucalopride 56 Zenvia Phase III 56 ExTRACT TIMI 56 Pivotal Trial 56 II Clinical Trial 56 Phase 2b Study 56 HuMax EGFr 56 Controlled Trial 56 controlled multicenter Phase 56 CABANA 56 Valsartan 56 Receptor Antagonists 56 Intravitreal 56 randomized multicenter 56 APPRAISE 56 randomized multicenter trial 55 Adenoma Prevention 55 Phase 2b Clinical Trial 55 PHASE III 55 MERLIN TIMI 55 teriflunomide 55 Adalimumab 55 Phase IIb Trial 55 ECASS 55 Phase Ib Clinical Trial 55 Saxagliptin 55 Cardiac Outcomes 55 Pooled Analysis 55 JAK Inhibitor 55 Glatiramer Acetate 55 ISIS # 55 Tezampanel 55 Trandolapril 55 VADT 55 AEGR 55 ISAR TEST 55 Scandinavian Simvastatin Survival 55 Phase III Clinical Trial 55 Alfimeprase 55 Fondaparinux 54 Contraindications 54 MEND CABG 54 Pramlintide 54 AIM HIGH 54 Mipomersen 54 Study Evaluating 54 Pulmonary Arterial Hypertension 54 Tanespimycin 54 Oral Insulin 54 LibiGel ® 54 Rosiglitazone 54 Neuroprotective Effects 54 ASCO abstract 54 Epanova 54 Telmisartan 54 Muraglitazar 54 Clinical Trial Evaluating 54 phase Ib 54 TRANSFORMS 54 phase IIb 54 pharmacokinetic PK study 54 Zarnestra 54 TLK# 54 cinacalcet 54 Olmesartan 54 fosbretabulin 54 AOD# [002] 54 CONQUER 54 Avastin bevacizumab 54 Intervention Effectiveness 53 Elagolix 53 APEX PD 53 Cinacalcet 53 vildagliptin 53 Dual Antiplatelet Therapy 53 Vidaza azacitidine 53 Aortic Stenosis 53 EVEREST II 53 Interferon Beta 53 See CLINICAL PHARMACOLOGY 53 icatibant 53 ZYBRESTAT TM 53 ILLUMINATE 53 guanfacine extended release 53 tocilizumab 53 CELLO 53 LAF# 53 Asthma Intervention 53 Prolongs Survival 53 Angiotensin Converting Enzyme 53 EURIDIS 53 PRoFESS 53 pioglitazone Actos 53 Bivalirudin 53 LENALIDOMIDE 53 Long Term Efficacy 53 bevacizumab Avastin 53 Blind Placebo Controlled Trial 53 atorvastatin Lipitor 53 Platelet Inhibition 53 Hormone Refractory Prostate Cancer 53 sorafenib Nexavar 53 MEVACOR 53 Left Ventricular Dysfunction 53 Pharmacokinetic PK 53 Orexigen Contrave 53 ACCOMPLISH 53 Vivus Qnexa 53 Tesamorelin 53 Benign Prostatic Hyperplasia 53 Antiviral Activity 53 Interferon Alfa 53 Sipuleucel T 53 Pivotal Phase III 53 multicenter phase 53 CONTRAINDICATIONS 53 Late Breaker 53 QT Prolongation 53 Phase III Clinical Trials 53 Relapsing Multiple Sclerosis 53 Meets Primary Endpoint 53 FDA APPROVES 53 prospective randomized placebo 53 Vernakalant 53 Knee Osteoarthritis 53 phase IIa 53 CARE HF 53 Multiethnic Study 53 taranabant 53 Lacosamide 53 Double Blind Placebo 53 Dasatinib 53 Ticagrelor 53 CLINICAL TRIALS 53 Prospective Multicenter 53 phase IIb study 52 Dose Escalation 52 PERSEUS 52 Phase III multicenter 52 BAL# [002] 52 Febuxostat 52 Myoblast 52 SANTE 52 Randomized Double blind 52 aripiprazole Abilify 52 SABCS 52 Bone Mineral Density 52 Prospective Randomized Trial 52 Diabetic Nephropathy 52 multicenter randomized controlled 52 colesevelam HCl 52 reslizumab 52 ORMD 52 Boceprevir 52 Clinical Trial Results 52 Cholesterol Levels SPARCL 52 Phase 1b Clinical Trial 52 Hypertensive Patients 52 Iloperidone 52 Bazedoxifene 52 FDA Oncologic Drugs 52 ASCEND HF 52 Tipranavir 52 sunitinib malate 52 Toremifene 52 Efficacy Study 52 SERENADE 52 HoFH 52 DCCR 52 Pioglitazone 52 subanalysis 52 NATRECOR ® 52 Randomized Comparison 52 Meta Analysis 52 Aliskiren 52 renal artery stenting 52 Natalizumab 52 Phase 2a clinical 52 Combination Treatment 52 CLOTS 52 ACE Inhibitor 52 Degarelix 52 cediranib 52 Controlled Study 52 Pharmacokinetic Study 52 Tocilizumab 52 phase 2a 52 FREEDOMS 52 Aflibercept 52 NEW DRUG 52 GW# [003] 52 vidofludimus 52 CAPRA 52 PYY #-# 52 Liraglutide 52 Betaferon R 52 AZILECT R 52 trodusquemine 52 Avanafil 52 Antiplatelet 52 arzoxifene 52 Intervention Trial GAIT 52 phase IIb clinical 52 Irbesartan 52 Intervention Effectiveness CATIE 52 platelet inhibitor 52 RezularTM 52 Safinamide 52 terlipressin 52 rosiglitazone Avandia 52 Insulin Glargine 52 Certriad 52 inhibitor rofecoxib 52 candesartan cilexetil 52 CUPID 52 multicenter randomized Phase 52 dual endothelin receptor antagonist 52 Egrifta 52 clazosentan 52 BCIRG 52 GUSTO 52 briakinumab 52 Randomized Evaluation 52 azilsartan medoxomil 52 Anticancer Agent 52 Receptor Agonist 52 infliximab Remicade 52 Ocrelizumab 52 Investigational Compound 51 Prostate AdenoCarcinoma Treatment 51 Celecoxib APC trial 51 EINSTEIN DVT 51 PSN# [002] 51 MYDICAR 51 SPIRIT FIRST 51 phentermine topiramate 51 multicenter prospective 51 TAXUS ATLAS 51 Improved Survival 51 Treated Patients 51 Carvedilol 51 NICE SUGAR 51 Complicated Skin 51 LY# [002] 51 REALITY Trial 51 alendronate Fosamax 51 Temsirolimus 51 BENICAR HCT 51 Efficacy Results 51 Observational Study 51 Tiotropium 51 Subgroup Analysis 51 ReoPro 51 Randomized Study 51 chromium supplementation 51 niacin laropiprant 51 fluvastatin 51 Tyrosine Kinase Inhibitor 51 Hypercholesterolemia 51 davalintide 51 ACTOS ® 51 Bosutinib 51 SCHERING PLOUGH 51 Desmoteplase 51 Rivaroxaban 51 olmesartan 51 Bifeprunox 51 Ophena TM 51 HuMax CD4 51 aripiprazole 51 Double Blind Randomized 51 Refractory Angina 51 Randomised 51 MATCHED 51 SUCCEED trial 51 HEART FAILURE 51 Vandetanib 51 Qnexa 51 Pirfenidone 51 Protease Inhibitor 51 Denufosol 51 multicentre 51 Fibrillex 51 Antihypertensive 51 phase IIa clinical 51 CRMD# 51 rosuvastatin calcium 51 Cardiovascular Outcomes 51 CYT# QbG# 51 oral rivaroxaban 51 HCV SPRINT 51 Sibutramine Cardiovascular Outcomes 51 Mycophenolate Mofetil 51 AGGRASTAT R Injection tirofiban 51 Oral Fingolimod 51 E1 INT 51 riociguat 51 Is Well Tolerated 51 interferon beta 1b 51 Cyclooxygenase 2 51 Vaprisol 51 PRISTIQ 51 Tarceva TM 51 Calcium Acetate 51 UNLOAD 51 PREOS R 51 pioglitazone HCl 51 eltrombopag 51 Dapagliflozin 51 Surgical Treatment 51 ENDEAVOR III 51 Sanvar 51 PREOS 51 Protease Inhibitors 51 Topiramate 51 CARDIOVASCULAR 51 cetuximab Erbitux 51 Phase 2a trial 51 Aurora Kinase 51 AZILECT ® 51 eprotirome 51 Corlux 51 Anticoagulant 51 IMPACT DCM 51 ® pioglitazone HCl 51 Phase 1a clinical 51 Androxal TM 51 Targretin 51 Genz # 51 ACTEMRA TM 51 sitaxsentan 50 Pemetrexed 50 Beneficial Effects 50 CELGENE 50 Ambrisentan 50 selective modulator 50 fenofibrate 50 Aggressive Drug Evaluation 50 PRT# 50 Coagulation 50 Randomized Double Blind Placebo 50 Peripheral Arterial 50 Biolimus A9 50 Ramipril 50 ranolazine 50 dose escalation clinical 50 KRN# 50 Clinical Efficacy 50 Antiviral Therapy 50 Overactive Bladder 50 Monotherapy 50 Placebo Controlled Trial 50 strontium ranelate 50 Naproxcinod 50 BARI 2D 50 antiarrhythmic 50 ZOLINZA 50 Adjuvant Chemotherapy 50 Epirubicin 50 Advanced Melanoma 50 Ziprasidone 50 Traficet EN 50 RIO Lipids 50 Demonstrates Potent 50 Randomized Controlled 50 Low Dose 50 neratinib 50 Arzerra TM 50 Pharmacodynamics 50 darapladib 50 Schizophrenia Treatment 50 lucinactant 50 Unstable Angina 50 Serada 50 Thromboembolism 50 Dendreon Provenge 50 Statistically Significant 50 lapatinib Tykerb 50 Kidney Transplant Patients 50 Darusentan 50 Randomized Double Blind 50 muraglitazar 50 Carotid Stenting 50 Xelox 50 BRIM3 50 Intuniv 50 SORT OUT 50 Postmarketing 50 CIMZIA TM 50 AVAPRO 50 SIMCOR 50 FDA Advisory Panel 50 Lucentis ranibizumab Genentech 50 AASLD Meeting 50 Vorapaxar 50 TREAT 50 Phase IIIb clinical 50 CETP inhibition 50 Stenting Trial CREST 50 FDA Endocrinologic 50 Celgene Revlimid 50 Val HeFT 50 Zybrestat 50 Glucosamine Chondroitin Arthritis 50 ATACAND 50 PROVENGE sipuleucel T 50 Proteasome 50 Phase 1b trial 50 HYPERTENSION 50 Phase IIa Clinical Trial 50 preclinical efficacy 50 antiplatelet agent 50 Systemic Sclerosis 50 RSD# 50 desvenlafaxine 50 Vildagliptin 50 randomized multicenter Phase III 50 Podium Presentation 50 inhibitor RG# 50 Glycemia 50 MADIT 50 Intervention Trial 50 Aptivus ® 50 Multiple Ascending Dose 50 Patency 50 Prognostic Significance 50 Hepatocellular Carcinoma 50 Placebo Controlled Study 50 Glufosfamide 50 RE LY trial 50 Enoxaparin 50 6R BH4 50 Teriflunomide 50 CIMZIA ™ 50 PROTECT AF 50 interferon gamma 1b 50 Non Alcoholic Steatohepatitis 50 PDE4 inhibitor 50 Insulin detemir 50 HORIZON 50 TMC# C# 50 DAPT 50 Crestor rosuvastatin 50 Acute Decompensated Heart Failure 50 Adjunctive 50 canakinumab 50 Nuvion 50 Investigational Agent 50 AstraZeneca Brilinta 50 Patients Treated With 49 ASBMR 49 FM VP4 49 IN PATIENTS WITH 49 Tolvaptan 49 Inhaled Insulin 49 abatacept 49 GP IIb IIIa inhibitors 49 AVERROES 49 ORAL Sync 49 MULTAQ 49 bosentan 49 phase IIb trial 49 IMPACT IMmunotherapy 49 Onrigin 49 elotuzumab 49 Phase Ib clinical 49 Cardiogenic Shock 49 Cochrane Database Syst Rev 49 ACTEMRA 49 alvimopan 49 Moxifloxacin 49 Previously Treated 49 TriRima 49 ximelagatran 49 Quinamed 49 CIMZIA TM certolizumab pegol 49 abacavir Ziagen 49 pramlintide 49 TBC# 49 Lu AA# 49 Carfilzomib 49 Dyloject TM 49 ORENCIA ® 49 Dalbavancin 49 AVASTIN 49 ibandronate 49 PREDICTIVE 49 Torisel 49 ONGLYZA ™ 49 coxib 49 ACTIVE W 49 Pravastatin 49 zoledronic acid Zometa 49 treatment naive genotype 49 axitinib 49 Focalin XR 49 Candesartan 49 Ataluren 49 Clinical Trial Data 49 desvenlafaxine succinate 49 Environ Health Perspect 49 Fungal Infections 49 Clinical Antipsychotic Trials 49 Dose Response 49 divalproex sodium 49 anti arrhythmic drug 49 Apixaban 49 Lenalidomide 49 RE LY ® 49 ACCORD Lipid 49 ONCOLOGY 49 celecoxib Celebrex 49 ALLEGRO 49 ribavirin USP 49 Ropinirole 49 Demonstrates Efficacy 49 imipramine Tofranil 49 mipomersen 49 Inhaled Corticosteroids 49 Patients Undergoing 49 Diabetic Neuropathy 49 pertuzumab 49 alemtuzumab Campath 49 antidiabetic drug 49 WYETH 49 lomitapide 49 liprotamase 49 HMG CoA reductase inhibitors 49 JOURNAL OF 49 RESIST 49 prospective multicentre 49 Severe Sepsis 49 REYATAZ R 49 ganetespib 49 Adjuvant Therapy 49 Suppl. 49 elagolix 49 Adjuvant Treatment 49 Aprotinin 49 malignant ascites 49 Pimavanserin 49 PPAR gamma agonists 49 pan histone deacetylase 49 fostamatinib 49 Teriparatide 49 verteporfin 49 Randomized controlled 49 PEGINTRON TM 49 Atacand 49 ARCOXIA 49 Dacogen decitabine 49 NOVARTIS 49 teduglutide 49 Clinical Practice Guideline 49 Romiplostim 49 Cardiotoxicity 49 THYROID 49 Multicentre 49 Ozarelix 49 Sustained Efficacy 49 atherosclerotic renal artery stenosis 49 amifostine 49 clevidipine 49 aldosterone antagonists 49 ASCOT 49 renoprotective 49 AVADO 49 lixisenatide 49 Antiepileptic Drug 49 lasofoxifene 49 NCCTG N# 49 varespladib 49 REMINYL ® 49 Celebrex celecoxib 49 oral ridaforolimus 49 Phase IIb Clinical Trial 49 MAGE A3 ASCI 49 Trial Evaluating 49 Preos 49 BLOOM 49 ELACYT 49 chronic thromboembolic pulmonary 49 oral cladribine 49 ASCO GI 49 HEART DISEASE 49 serotonin norepinephrine reuptake inhibitor 49 Beta Blocker 49 placebo controlled studies 49 Antitumor Activity 49 Arch Neurol 49 Clinical Outcome 49 CTRC AACR San Antonio 49 Hepatotoxicity 49 Bioequivalence 49 Qnexa TM 49 Novel Antibiotic 49 Fabry Disease 49 Azacitidine 48 Renal Cell Carcinoma 48 Randomized Phase II 48 TREATMENT OF 48 troglitazone 48 Benlysta belimumab 48 Eszopiclone 48 multicenter multinational 48 Vicriviroc 48 Duloxetine 48 Well Tolerated 48 Zemplar Capsules 48 oral Xeloda 48 NSABP B 48 Panitumumab 48 Phase 1b 48 Injectafer 48 PROSTATE 48 Cloretazine 48 Prevent Stroke 48 Carotid Endarterectomy 48 Ixempra 48 Duodenal 48 Acapodene 48 ivabradine 48 abatacept Orencia 48 QNEXA ® 48 Treprostinil 48 Initiate Clinical Trial 48 VICTOR E3 48 pramlintide metreleptin 48 Replacement Therapy 48 Menerba 48 iniparib 48 insulin sensitizing 48 AHA Scientific Sessions 48 GASTRIC 48 Rofecoxib 48 XL# SAR# 48 ADA Scientific Sessions 48 CoFactor 48 Fablyn 48 Bicifadine 48 LEVAQUIN 48 Vertex telaprevir 48 Metabolic Endocrinology 48 DU #b 48 multicenter Phase II 48 Randomized Controlled Trials 48 Phase III randomized controlled 48 Novel Mechanism 48 Avandia rosiglitazone 48 Percutaneous Tibial Nerve Stimulation 48 daclizumab 48 zonisamide SR 48 piroxicam 48 MEND CABG II 48 Oral Formulation 48 First Patient Enrolled 48 ocrelizumab 48 First Patient Dosed 48 selective androgen receptor modulator 48 CRx 48 AND RECOMMENDATIONS 48 PROactive study 48 CTAP# Capsules 48 Aromatase Inhibitors 48 Heart Failure Patients 48 Thiazolidinediones 48 CombAT 48 AIR2 Trial 48 venlafaxine Effexor 48 Spiriva Handihaler 48 Ceflatonin 48 nimodipine 48 olanzapine Zyprexa 48 EFFEXOR XR 48 TYKERB 48 Sprycel dasatinib 48 Heterozygous Familial Hypercholesterolemia 48 Nexium esomeprazole 48 BiTE antibody MT# 48 Pemphigus Vulgaris 48 S#.# [006] 48 Cannabinoid 48 Triolex 48 IND Application 48 pitavastatin 48 selegiline 48 Pharmacodynamic 48 Rezular 48 landmark ATHENA trial 48 glatiramer acetate 48 ProSavin 48 Losartan 48 STELLAR 48 Lorqess 48 alogliptin 48 oral dual endothelin 48 SCH # 48 FASLODEX 48 Combination REOLYSIN R 48 aclidinium 48 INCB# [003] 48 torezolid phosphate 48 Microalbuminuria 48 Lipid Lowering Treatment 48 Suicidality 48 valsartan Diovan 48 Rotavirus Vaccine 48 rosiglitazone 48 RECORD1 48 Roflumilast 48 QVA# 48 GlaxoSmithKline Avandia 48 albiglutide 48 EDEMA4 48 Decitabine 48 Cimzia TM 48 LymphoStat B 48 PIX# [002] 48 donepezil Aricept 48 Peptic Ulcer 48 TO AVOID PREGNANCY WHILE 48 tolvaptan 48 Immunogenicity 48 TORISEL TM 48 GALNS 48 RENAL 48 HYVET 48 HCV RESPOND 2 48 WelChol 48 sibutramine Meridia 48 RhuDex R 48 ixabepilone 48 Multicenter Study 48 ACEIs 48 HEART HEALTH 48 unfractionated heparin UFH 48 CHARISMA 48 Nebulized 48 Varisolve 48 Novel Therapies 48 INCB# [001] 48 Pivotal Phase II 48 Stenting Trial 48 Vytorin ezetimibe 48 plasminogen activators 48 Xinlay 48 hormone therapy HT 48 PTK ZK 48 TG MV 48 incyclinide 48 Zoraxel 48 Enbrel etanercept 48 Nesiritide 48 Endarterectomy 48 Aplidin 48 Carotid Revascularization Endarterectomy vs. 48 Mirapexin 48 tesofensine 48 eculizumab therapy 48 noninferior 48 approvability 48 NV1FGF 48 vernakalant hydrochloride 48 levetiracetam Keppra 48 metformin sulfonylurea 48 Diabetic Patients 48 Pharmacokinetic 48 telcagepant 48 Novel Oral 48 intravitreal implant 48 Thrombolysis 48 Investigational Drug 47 Sustained Release 47 β blockers 47 THERAPEUTICS 47 Carotid Artery Stenting 47 PROMACTA 47 Velcade bortezomib 47 CHAMPION PCI 47 Ischemic Stroke 47 brimonidine 47 FTY# fingolimod 47 sitagliptin 47 Rosiglitazone Evaluated 47 aclidinium bromide 47 antithrombotic therapies 47 Regeneron Pharma 47 Phase 2a Trial 47 Icatibant 47 metaglidasen 47 Sevelamer 47 Estrogen Receptor 47 Tigecycline 47 International Verapamil SR 47 Eltrombopag 47 GATTEX TM 47 visilizumab 47 efficacy endpoint 47 Diabetic Macular Edema DME 47 NO MORE EXCUSES 47 Morquio 47 bisoprolol 47 Phenoptin 47 Androxal 47 HuMax CD# 47 intensive lipid lowering 47 TAXOTERE ® 47 methylnaltrexone 47 VAPRISOL 47 ABSTRACTS 47 lumiliximab 47 Infliximab 47 PROACTIVE 47 MEDTRONIC 47 NCT# ClinicalTrials.gov 47 zoledronate 47 Myocardial Infarction Study 47 Attenuates 47 ACOMPLIA R 47 Nuclear Receptors 47 CLL8 47 Histalean 47 MK #A [001] 47 Vitro Activity 47 tanespimycin 47 Desvenlafaxine Succinate 47 Autoimmune Disease 47 Analytical Tool 47 ENDEAVOR 47 Nymox NX 47 Patient Outcomes 47 FIBROMYALGIA 47 Elderly Patients 47 zalutumumab 47 INVIRASE 47 ritonavir boosted 47 dalbavancin 47 Fixed Dose 47 Atomoxetine 47 Venous Thromboembolism 47 EDEMA3 47 trastuzumab Herceptin 47 pomalidomide 47 Arcalyst 47 Vivus VVUS 47 Phase #/#a trial 47 Acute Coronary Syndrome 47 Welchol 47 Pfizer Sutent 47 Study GL# 47 ketoprofen patch 47 Glybera R 47 Multicenter Phase 47 Lilly Zyprexa 47 T Pred 47 ALGRX 47 FDA Pulmonary Allergy 47 Endothelial Function 47 lorcaserin hydrochloride 47 Bucindolol 47 Zerenex 47 Reduce Cardiovascular 47 mycophenolate mofetil 47 Zoloft sertraline 47 Peginterferon Alfa 2a 47 Placebo controlled 47 Sanctura XR 47 VA# [002] 47 paroxetine Paxil 47 enzastaurin 47 CYCLOSET 47 valvulopathy 47 Breaking Clinical Trials 47 Emselex 47 Radiation Therapy Oncology 47 JANUVIA 47 Acute Stroke 47 Rebif ® 47 AFRESA 47 insulin sensitizers 47 Lung Injury 47 Amrubicin 47 ToGA 47 pioglitazone 47 iclaprim 47 ruboxistaurin 47 ≥ Grade 47 J Natl Cancer Inst 47 Decompensated Heart Failure 47 Amyvid 47 Renal Function 47 Serdaxin 47 Drug Candidate 47 ASSERT 47 zanolimumab 47 Myelodysplastic Syndromes 47 Arena Pharmaceuticals ARNA 47 viral kinetic 47 dronedarone 47 Azathioprine 47 IFN β 47 Metabolic Disease 47 Ischemic 47 Metabolic Drugs Advisory 47 omacetaxine mepesuccinate 47 Chronic Heart Failure 47 RoACTEMRA 47 PegIntron 47 subgroup analyzes 47 ALB # 47 Novel Inhibitor 47 CYP#A# CYP#D# 47 AstraZeneca Crestor 47 Postmenopausal Women 47 Mylotarg 47 Clinical Evaluation 47 Kinase Inhibitor 47 Starlix 47 Amplimexon 47 pravastatin sodium tablets 47 ORENCIA R 47 #-# Full Text 47 NATRECOR R 47 Meridia sibutramine 47 Mg Usa 47 phase Ib clinical 47 Mimetics 47 ENDO 47 LDL lowering 47 Solesta 47 Outpatient Setting 47 lintuzumab 47 Sitagliptin 47 Proteinuria 47 teratogenicity 47 CRLX# 47 Levetiracetam 47 efalizumab 47 Risk Stratification 47 Prostate Cancer Progression 47 romiplostim 47 Systolic Hypertension 47 balsalazide tablet 47 acute gout 47 PFIZER 47 Receives Orphan Drug Designation 47 platelet inhibition 47 SinuNase 47 formoterol fumarate 47 MEDICATIONS 47 Golimumab 47 Zometa zoledronic acid